Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China. Facilities include a bio-laboratory, which, the company said, “significantly enhances capabilities for internal project development initiatives and material supply into the domestic life science market”.